Sugi Predict

Sugi Predict / Targets / PPID

PPID

Peptidyl-prolyl cis-trans isomerase D · Q08752 · PPID on Sugi Atlas →

11,385 patent compounds predicted against PPID, 7,308 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL2038175 SCHEMBL2038175 1.00 19/20
SCHEMBL2039673 SCHEMBL2039673 1.00 19/20
SCHEMBL2035819 SCHEMBL2035819 1.00 18/20
SCHEMBL2038219 SCHEMBL2038219 1.00 18/20
SCHEMBL2035499 SCHEMBL2035499 1.00 17/20
SCHEMBL2035501 SCHEMBL2035501 1.00 17/20
SCHEMBL2039389 SCHEMBL2039389 1.00 17/20
SCHEMBL2039766 SCHEMBL2039766 1.00 17/20
SCHEMBL2035376 SCHEMBL2035376 0.94 17/20
SCHEMBL2035436 SCHEMBL2035436 0.72 17/20
SCHEMBL2033696 SCHEMBL2033696 0.72 17/20
SCHEMBL2034766 SCHEMBL2034766 0.79 14/20
SCHEMBL2040168 SCHEMBL2040168 0.79 14/20
SCHEMBL2032655 SCHEMBL2032655 0.75 13/20
SCHEMBL2035755 SCHEMBL2035755 0.64 13/20
SCHEMBL2037683 SCHEMBL2037683 0.76 12/20
SCHEMBL2039280 SCHEMBL2039280 0.73 12/20
SCHEMBL2037088 SCHEMBL2037088 0.67 12/20
SCHEMBL2037719 SCHEMBL2037719 1.00 11/20
SCHEMBL2040043 SCHEMBL2040043 0.78 11/20

Clinical trials — most relevant to PPID by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From Real World PHASE4UNKNOWN
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia PHASE3COMPLETED
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia PHASE2WITHDRAWN
Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer. PHASE1/PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. PHASE2COMPLETED
Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria PHASE1COMPLETED
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES) nanUNKNOWN
Genes-in-Action - Hepcidin Regulation of Iron Supplementation nanCOMPLETED
Sensorimotor Gating in Schizophrenia nanCOMPLETED
Genotype-supported Versus Conventional Proton Pump Inhibitor Dosing nanCOMPLETED
Identification of Acute Intermittent Porphyria Modifying Genes nanRECRUITING
Portable Measurement of Protoporphyrin IX in the Skin nanCOMPLETED
Biomarkers in the Diagnosis and Prognosis of NAFLD nanRECRUITING
Effect of Migalastat on Cardiac Involvement in Fabry Disease nanCOMPLETED
Cerebellar Mutism Syndrome Study nanRECRUITING
Ovarian Reserve and Matrix Metalloproteinases nanCOMPLETED
Parkinson's Diseases Susceptibility Genes and Pesticides nanCOMPLETED
Peripheral Perfusion Index in Acute Surgical Patients nanCOMPLETED
Timecourse of Immobilization Experiment nanCOMPLETED
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Biomarkers in Idiopathic Juvenile Arthritis nanUNKNOWN
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies nanENROLLING_BY_INVITATION
Analysis by Clinical Mass Spectrometry of Bloodstains nanCOMPLETED
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome nanUNKNOWN
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease nanWITHDRAWN
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease nanWITHDRAWN
Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a PPID binder may also engage these)

ProteinNameSimilarity
Q9CR16 — 1.000 Q9CR16 →
P26882 — 1.000 P26882 →
Q6DGG0 — 0.998 Q6DGG0 →
Q5U8Z7 — 0.998 Q5U8Z7 →
Q6CBP4 — 0.996 Q6CBP4 →
Q5B4E7 — 0.996 Q5B4E7 →
Q9C566 — 0.995 Q9C566 →
Q2U0E0 — 0.994 Q2U0E0 →
P0C1I1 — 0.993 P0C1I1 →
Q9P3X9 — 0.991 Q9P3X9 →
Q6CL78 — 0.991 Q6CL78 →
Q4WIF3 — 0.991 Q4WIF3 →
P53691 — 0.991 P53691 →
Q4HXF6 — 0.990 Q4HXF6 →
Q5ACI8 — 0.990 Q5ACI8 →
Q6FNU6 — 0.990 Q6FNU6 →
Q6BXZ7 — 0.990 Q6BXZ7 →
P0CP81 — 0.988 P0CP81 →
P0CP80 — 0.987 P0CP80 →
P0C1I2 — 0.987 P0C1I2 →
Q11004 — 0.986 Q11004 →
Q9TRY0 — 0.986 Q9TRY0 →
Q9ZVJ4 — 0.985 Q9ZVJ4 →
Q4P0V4 — 0.985 Q4P0V4 →
P0CP79 — 0.984 P0CP79 →
Q75A33 — 0.984 Q75A33 →
Q7S7Z6 — 0.984 Q7S7Z6 →
Q43207 — 0.984 Q43207 →
Q5U2T9 — 0.984 Q5U2T9 →
Q9QZH3 — 0.984 Q9QZH3 →